Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD)
- PMID: 26484906
- DOI: 10.3233/JAD-150350
Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD)
Abstract
The involvement of transporters located at the blood-brain barrier (BBB) has been suggested in the control of cerebral Aβ levels, and thereby in Alzheimer's disease (AD). However, little is known about the regulation of these transporters at the BBB in animal models of AD. In this study, we investigated the BBB expression of Aβ influx (Rage) and efflux (Abcb1-Abcg2-Abcg4-Lrp-1) transporters and cholesterol transporter (Abca1) in 3-18-month-old 3xTg-AD and control mice. The age-dependent effect of BBB transporters regulation on the brain uptake clearance (Clup) of [3H]cholesterol and [3H]Aβ1 - 40 was then evaluated in these mice, using the in situ brain perfusion technique. Our data suggest that transgenes expression led to the BBB increase in Aβ influx receptor (Rage) and decrease in efflux receptor (Lrp-1). Our data also indicate that mice have mechanisms counteracting this increased net influx. Indeed, Abcg4 and Abca1 are up regulated in 3- and 3/6-month-old 3xTg-AD mice, respectively. Our data show that the balance between the BBB influx and efflux of Aβ is maintained in 3 and 6-month-old 3xTg-AD mice, suggesting that Abcg4 and Abca1 control the efflux of Aβ through the BBB by a direct (Abcg4) or indirect (Abca1) mechanism. At 18 months, the BBB Aβ efflux is significantly increased in 3xTg-AD mice compared to controls. This could result from the significant up-regulation of both Abcg2 and Abcb1 in 3xTg-AD mice compared to control mice. Thus, age-dependent regulation of several Aβ and cholesterol transporters at the BBB could ultimately limit the brain accumulation of Aβ.
Keywords: 3xTg-AD; ABCA1; ABCB1; ABCG2; ABCG4; Alzheimer’s disease; Oatp1a4; RAGE; amyloid-β; blood-brain barrier; cholesterol.
Similar articles
-
ABCG2- and ABCG4-mediated efflux of amyloid-β peptide 1-40 at the mouse blood-brain barrier.J Alzheimers Dis. 2012;30(1):155-66. doi: 10.3233/JAD-2012-112189. J Alzheimers Dis. 2012. PMID: 22391220
-
ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.J Neurosci. 2009 Apr 29;29(17):5463-75. doi: 10.1523/JNEUROSCI.5103-08.2009. J Neurosci. 2009. PMID: 19403814 Free PMC article.
-
Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.Biochim Biophys Acta Mol Basis Dis. 2019 Sep 1;1865(9):2224-2245. doi: 10.1016/j.bbadis.2019.04.019. Epub 2019 May 2. Biochim Biophys Acta Mol Basis Dis. 2019. PMID: 31055081
-
Role of ABC transporters in the pathogenesis of Alzheimer's disease.ACS Chem Neurosci. 2012 Nov 21;3(11):820-31. doi: 10.1021/cn300077c. Epub 2012 Oct 11. ACS Chem Neurosci. 2012. PMID: 23181169 Free PMC article. Review.
-
The Interplay of ABC Transporters in Aβ Translocation and Cholesterol Metabolism: Implicating Their Roles in Alzheimer's Disease.Mol Neurobiol. 2021 Apr;58(4):1564-1582. doi: 10.1007/s12035-020-02211-x. Epub 2020 Nov 19. Mol Neurobiol. 2021. PMID: 33215389 Review.
Cited by
-
Cerebrovascular insulin receptors are defective in Alzheimer's disease.Brain. 2023 Jan 5;146(1):75-90. doi: 10.1093/brain/awac309. Brain. 2023. PMID: 36280236 Free PMC article.
-
Potential microRNA-related targets in clearance pathways of amyloid-β: novel therapeutic approach for the treatment of Alzheimer's disease.Cell Biosci. 2019 Nov 12;9:91. doi: 10.1186/s13578-019-0354-3. eCollection 2019. Cell Biosci. 2019. PMID: 31749959 Free PMC article. Review.
-
The role of amyloid beta clearance in cerebral amyloid angiopathy: more potential therapeutic targets.Transl Neurodegener. 2017 Aug 17;6:22. doi: 10.1186/s40035-017-0091-7. eCollection 2017. Transl Neurodegener. 2017. PMID: 28824801 Free PMC article. Review.
-
Clearance of interstitial fluid (ISF) and CSF (CLIC) group-part of Vascular Professional Interest Area (PIA), updates in 2022-2023. Cerebrovascular disease and the failure of elimination of Amyloid-β from the brain and retina with age and Alzheimer's disease: Opportunities for therapy.Alzheimers Dement. 2024 Feb;20(2):1421-1435. doi: 10.1002/alz.13512. Epub 2023 Oct 28. Alzheimers Dement. 2024. PMID: 37897797 Free PMC article. Review.
-
Melatonin ameliorates microvessel abnormalities in the cerebral cortex and hippocampus in a rat model of Alzheimer's disease.Neural Regen Res. 2021 Apr;16(4):757-764. doi: 10.4103/1673-5374.295349. Neural Regen Res. 2021. PMID: 33063739 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous